Expansion of the fungicide portfolio through acquisitions and product introductions
First written in FY2020-Q3. 2 of 6 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024WorsenedAnnual report
「Because the initially projected earnings from the Company’s quinoxyfen business could no longer be expected, its carrying amount was reduced to its recoverable amount, and the reduction was recorded as an impairment loss under extraordinary losses.」
The initially projected earnings from the acquired quinoxyfen business could no longer be expected, resulting in an impairment loss of ¥823 million. Deterioration in earnings has occurred in part of the fungicide portfolio expansion through acquisitions and in-licensing. - FY2022-Q3RestatedAnnual report
「In addition, Daisen, the fungicide acquired in the third quarter of the previous fiscal year, contributed to sales both in Japan and overseas.」
The acquired Daisen fungicide is contributing to agricultural chemicals sales in Japan and overseas, showing the continuing effects of portfolio expansion through acquisitions and in-licensing. - FY2022-Q2AdvancedAnnual report
「Domestic sales of agricultural chemicals were solid for Roundup, a non-selective foliar-applied herbicide, while Daisen, the fungicide acquired in the third quarter of the previous fiscal year, contributed to sales.」
The acquired Daisen fungicide contributed to domestic agricultural chemicals sales, demonstrating the impact of expanding the fungicide portfolio through acquisitions and in-licensing. - FY2021-Q3AdvancedAnnual report
「On 18 December 2020, the Company entered into a business transfer agreement to acquire Corteva Agriscience’s manzeb fungicide business and acquired the business on the same date. The aim was to further develop its agricultural chemicals business by expanding its fungicide portfolio through acquisitions and in-licensing, in addition to in-house drug discovery.」
The Company acquired the manzeb fungicide business for ¥5,384 million, further expanding its fungicide portfolio. - FY2021-Q2RestatedAnnual report
「Overseas sales of agricultural chemicals were solid for Greacia and Quintec, the fungicide acquired in the third quarter of the previous fiscal year.」
The Company said overseas sales of its fungicide portfolio, including the acquired Quintec, were solid. - FY2020-Q3First statedAnnual report
「On 29 November 2019, the Company entered into a business transfer agreement to acquire Corteva Agriscience’s quinoxyfen fungicide business and acquired the business on the same date. The aim was to further develop its agricultural chemicals business by expanding its fungicide portfolio through acquisitions and in-licensing, in addition to in-house drug discovery.」
The Company acquired Corteva Agriscience’s quinoxyfen business on 29 November 2019 for ¥6,335 million and identified the expansion of its fungicide portfolio through acquisitions and in-licensing as a new initiative.